PPARG and neoplasm: The findings of this study provide rationale to suggest that dogs with primary lung tumor and metastatic osteosarcoma could serve as a population which would be appropriate to treat with PPAR-γ agonists, and that expression of PPAR-γ can be demonstrated in these tumor types.